Nimotuzumab Dosing and Outcomes in Locally Advanced Head and Neck Cancer.

Joshi, A; Patil, V M; Noronha, V; Abhyankar, A; Menon, N; Prabhash, K

Joshi, A; Patil, V M; Noronha, V; Abhyankar, A; Menon, N; Prabhash, K.

Afiliação

Joshi A; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India.
Patil VM; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India.
Noronha V; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India.
Abhyankar A; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India.
Menon N; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India.
Prabhash K; Department of Medical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India.

Clin Oncol (R Coll Radiol) ; 32(1): e36, 2020 01.

Article em En | MEDLINE | ID: mdl-31353134

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google